Canopy Growth (CGC) Cost of Revenue (2019 - 2026)
Canopy Growth (CGC) posted Cost of Revenue of $109.0 million for Q4 2025, up 234.88% sequentially from $32.5 million in Q3 2025, and up 200.44% YoY from $36.3 million in Q4 2024.
Canopy Growth (CGC) Cost of Revenue (2019 - 2026) Analysis & Trends
Canopy Growth has reported Cost of Revenue for 7 years, with the latest figure at $109.0 million in Q4 2025.
- Quarterly Cost of Revenue rose 200.44% year-over-year to $109.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $216.8 million (up 54.26% YoY) and the FY2026 annual result came in at $156.7 million, up 18.69% from the prior year.
- Cost of Revenue advanced to $109.0 million in Q4 2025 per CGC's latest filing, from $32.5 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $174.3 million in Q1 2022 and troughed at $30.2 million in Q3 2024.
- A 5-year average of $73.1 million and a median of $58.7 million in 2022 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2025: Cost of Revenue slumped 57.8% in 2022, then jumped 200.44% in 2025.
- Over 5 years, Cost of Revenue stood at $103.8 million in 2021, then tumbled by 43.51% to $58.7 million in 2022, then plunged by 37.04% to $36.9 million in 2023, then declined by 1.8% to $36.3 million in 2024, then surged by 200.44% to $109.0 million in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods registered $109.0 million, $32.5 million, and $39.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 434.93 Mn | 187.92 Mn | 16.08 Mn | 42.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.60 Mn |
| Jun 30, 2026 | 42.60 Mn |
| Dec 31, 2025 | 108.96 Mn |
| Dec 31, 2025 | 108.96 Mn |
| Sep 30, 2025 | 32.54 Mn |
| Sep 30, 2025 | 32.54 Mn |
| Jun 30, 2025 | 39.04 Mn |
| Jun 30, 2025 | 39.04 Mn |
| Dec 31, 2024 | 36.27 Mn |
| Dec 31, 2024 | 36.27 Mn |
| Sep 30, 2024 | 30.17 Mn |
| Sep 30, 2024 | 30.17 Mn |
| Jun 30, 2024 | 31.57 Mn |
| Jun 30, 2024 | 31.57 Mn |
| Mar 31, 2024 | 42.54 Mn |
| Mar 31, 2024 | 42.54 Mn |
| Dec 31, 2023 | 36.93 Mn |
| Dec 31, 2023 | 36.93 Mn |
| Sep 30, 2023 | 34.44 Mn |
| Sep 30, 2023 | 34.44 Mn |